Lv11
30 积分 2024-08-15 加入
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
5小时前
待确认
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
1个月前
已完结
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
1个月前
已完结
Pilot Study of Nectin-4–Targeted PET Imaging Agent68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human
2个月前
已完结
Radiolabeled peptide probe for tumor imaging
8个月前
已完结
PET/MRI: A luxury or a necessity?
9个月前
已完结
皖公网安备34019202002308
